Endovascular Treatment Devices Market Overview, Growth, and Trends (2021-2031)

MARKET INTRODUCTION

Endovascular surgery is an innovative and minimally invasive procedure which is used to treat medical conditions affecting the blood vessels, such as an aneurysm, which is a swelling or "ballooning" of the blood vessel. The surgery involves making a small incision on the body part to access the blood vessels. In some cases, standard endovascular repair is not always feasible for patients. Sometimes the aneurysm is too close to important branches of the aorta or the arteries are too narrow or too complicated to permit passage of the catheter used in endovascular surgery. In such cases the patient can either opt for open surgery or no surgery.

MARKET DYNAMICS

The endovascular treatment devices market is anticipated to grow in the forecast, owing to the factors such increasing geriatric population base, increasing prevalence of cardiovascular diseases, technologically advanced endovascular products, increasing expenditure on research and development by industry players in the market during the forecast period. However high cost of endovascular procedures, lack of awareness in economically poor countries and shortage of skilled surgeons to perform the surgeries are the factors hampering the market growth.

MARKET SCOPE

The "Global Endovascular treatment devices Market Analysis to 2031" is a specialized and in-depth study of the medical devices industry with a special focus on the global market trend analysis. The report aims to provide an overview of endovascular treatment devices market with detailed market segmentation by product type, procedures, applications, end user and geography. The global endovascular treatment devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading endovascular treatment devices market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global endovascular treatment devices market is segmented on the basis of product type, procedures, applications, end user and geography. Based on product type, the market is segmented as percutaneous endovascular aneurysm repair (EVAR), fenestrated EVAR, aortic stents, biodegradable stents, self-expanding nitinol stents, thoracic aortic aneurysms grafts and other devices. On the basis of procedures, the global endovascular treatment devices market is segmented into, balloon angioplasty, angioplasty with stent placement, drug-eluting stents (DES), renal artery angioplasty and stenting, carotid artery stenting, transfemoral carotid artery stenting, transcarotid artery revascularization, intravascular brachytherapy, atherectomy, thrombolysis. Based on application the endovascular treatment devices market is segmented into pulmonary, vascular, cardiology, surgery, neurology and radiology. On the basis of end user, the global endovascular treatment devices market is segmented into hospitals, clinics and research institutes.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global endovascular treatment devices market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The endovascular treatment devices market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting endovascular treatment devices market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the endovascular treatment devices market in these regions.

MARKET PLAYERS

The reports cover key developments in the endovascular treatment devices market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from endovascular treatment devices market are anticipated to lucrative growth opportunities in the future with the rising demand for endovascular treatment devices market in the global market. Below mentioned is the list of few companies engaged in the endovascular treatment devices market.

The report also includes the profiles of key endovascular treatment devices market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

• Cardinal Health
• Boston Scientific
• Endospan
• Getinge AB
• InspireMD
• Japan Lifeline
• Lombard Medical Technologies
• Medtronic
• Penumbra
• Terumo Corporation

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Endovascular Treatment Devices Report Scope